Consumer Defensive
Reliv' International, Inc.(RELV)
Live Price
Offline$2.17
+0.00% today
1Y Change
-2.60%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- โ
- Revenue Growth
- -2.1%
- EPS Growth
- +21.9%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Reliv' International, Inc. (RELV) is a Consumer Defensive stock with listed on OTC. The stock last traded around $2.17 and down 2.6% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -2.1%, EPS growth of +21.9%, a dividend yield of 0.0%. What stands out right now is revenue -2.1%, EPS +21.9%, free cash flow -43.5% with operating margin -8.2% and ROIC -18.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RELV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-2.1% vs +1.7% peer median
Operating Margin
Below sector median
-8.2% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Sep 30, 2023, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -2.1% and EPS is at +21.9%, with operating margin around -8.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2023 Sep 30, 2023 | โ | +0.0% | +0.0% | +12.1% |
2023 Jun 30, 2023 | โ | +0.0% | +0.0% | +12.1% |
2023 Mar 31, 2023 | โ | +0.0% | +0.0% | +12.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RELV
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RELV Max Drawdown
-33.33%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RELV and SPY.
Company Overview
Reliv' International, Inc.
Other OTC
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.
- Leadership
- Ryan A. Montgomery
- IPO Date
- May 2, 2016
- Employees
- 91
- Street Address
- 136 Chesterfield Industrial Blvd, PO Box 405
- Mailing
- Chesterfield Missouri, MO, 63005
- Region
- Chesterfield Missouri, MO, US
- Reporting Currency
- USD
- Investor Line
- 16365379715
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.2
- Price/Book
- 0.4
Growth
- Revenue
- -2.1%
- EPS
- +21.9%
- Free Cash Flow
- -43.5%
Profitability
- Gross Margin
- 43.8%
- Operating Margin
- -8.2%
- Net Margin
- -7.5%
- ROE
- -22.4%
- ROIC
- -18.3%
Balance Sheet
- Debt/Equity
- 0.37
- Current Ratio
- 4.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.